Adjuvant Systemic Treatment for Oestrogen-receptor (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) Multicentre Phase III Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aromatase inhibitors; Cyclophosphamide; Docetaxel; Doxorubicin; Doxorubicin liposomal; Tamoxifen
- Indications Breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms ASTER 70s
- 16 Jun 2021 Biomarkers information updated
- 05 Jun 2012 Study design reported in abstract at 48th Annual Meeting of the American Society of Clinical Oncology.
- 30 Mar 2012 New trial record